Back to 
Capital World Investors
Capital World Investors
BCRX
Showing 0 of 3 quarters
Position history for Capital World Investors's holdings in BIOCRYST PHARMACEUTICALS INC
No. Capital World Investors exited its BCRX (Biocryst Pharmaceuticals) position in Q4 2019. Its Q3 2019 13F listed 2,840,000 shares worth $8.1M. Capital World Investors already held BCRX in its Q2 2019 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.